280 related articles for article (PubMed ID: 9088911)
1. Characteristics of age-related behavioral changes in senescence-accelerated mouse SAMP8 and SAMP10.
Miyamoto M
Exp Gerontol; 1997; 32(1-2):139-48. PubMed ID: 9088911
[TBL] [Abstract][Full Text] [Related]
2. Senescence-accelerated mouse (SAM) with special references to neurodegeneration models, SAMP8 and SAMP10 mice.
Takeda T
Neurochem Res; 2009 Apr; 34(4):639-59. PubMed ID: 19199030
[TBL] [Abstract][Full Text] [Related]
3. [Experimental techniques for developing new drugs acting on dementia (8)--Characteristics of behavioral disorders in senescence-accelerated mouse (SAMP8): possible animal model for dementia].
Miyamoto M
Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Oct; 14(5):323-35. PubMed ID: 7856329
[TBL] [Abstract][Full Text] [Related]
4. Early onset of behavioral alterations in senescence-accelerated mouse prone 8 (SAMP8).
Yanai S; Endo S
Behav Brain Res; 2016 Jul; 308():187-95. PubMed ID: 27093926
[TBL] [Abstract][Full Text] [Related]
5. Age-related alterations in the expression of glial cell line-derived neurotrophic factor in the senescence-accelerated mouse brain.
Miyazaki H; Okuma Y; Nomura J; Nagashima K; Nomura Y
J Pharmacol Sci; 2003 May; 92(1):28-34. PubMed ID: 12832852
[TBL] [Abstract][Full Text] [Related]
6. Neuropathological studies on strains of senescence-accelerated mice (SAM) with age-related deficits in learning and memory.
Kawamata T; Akiguchi I; Yagi H; Irino M; Sugiyama H; Akiyama H; Shimada A; Takemura M; Ueno M; Kitabayashi T; Ohnishi K; Seriu N; Higuchi K; Hosokawa M; Takeda T
Exp Gerontol; 1997; 32(1-2):161-9. PubMed ID: 9088913
[TBL] [Abstract][Full Text] [Related]
7. [Senescence-accelerated mouse (SAM): with special reference to age-associated pathologies and their modulation].
Takeda T
Nihon Eiseigaku Zasshi; 1996 Jul; 51(2):569-78. PubMed ID: 8783874
[TBL] [Abstract][Full Text] [Related]
8. Depressive behavior and alterations in receptors for dopamine and 5-hydroxytryptamine in the brain of the senescence accelerated mouse (SAM)-P10.
Onodera T; Watanabe R; Tha KK; Hayashi Y; Murayama T; Okuma Y; Ono C; Oketani Y; Hosokawa M; Nomura Y
Jpn J Pharmacol; 2000 Aug; 83(4):312-8. PubMed ID: 11001177
[TBL] [Abstract][Full Text] [Related]
9. Senescence-accelerated mouse (SAM): a novel murine model of senescence.
Takeda T; Hosokawa M; Higuchi K
Exp Gerontol; 1997; 32(1-2):105-9. PubMed ID: 9088907
[TBL] [Abstract][Full Text] [Related]
10. Senescence-accelerated mouse (SAM) as an animal model of senile dementia: pharmacological, neurochemical and molecular biological approach.
Okuma Y; Nomura Y
Jpn J Pharmacol; 1998 Dec; 78(4):399-404. PubMed ID: 9920195
[TBL] [Abstract][Full Text] [Related]
11. Assessment of social interaction and anxiety-like behavior in senescence-accelerated-prone and -resistant mice.
Meeker HC; Chadman KK; Heaney AT; Carp RI
Physiol Behav; 2013 Jun; 118():97-102. PubMed ID: 23672852
[TBL] [Abstract][Full Text] [Related]
12. Effects of a sustained release formulation of thyrotropin-releasing hormone on behavioral abnormalities in senescence-accelerated mice.
Miyamoto M; Hirai K; Heya T; Nagaoka A
Eur J Pharmacol; 1994 Dec; 271(2-3):357-66. PubMed ID: 7705436
[TBL] [Abstract][Full Text] [Related]
13. Age-related changes in anxiety are task-specific in the senescence-accelerated prone mouse 8.
Chen GH; Wang C; Yangcheng HY; Liu RY; Zhou JN
Physiol Behav; 2007 Aug; 91(5):644-51. PubMed ID: 17481677
[TBL] [Abstract][Full Text] [Related]
14. The senescence-accelerated prone mouse (SAMP8): a model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer's disease.
Butterfield DA; Poon HF
Exp Gerontol; 2005 Oct; 40(10):774-83. PubMed ID: 16026957
[TBL] [Abstract][Full Text] [Related]
15. Cholinesterase activity in brain of senescence-accelerated-resistant mouse SAMR1 and its variation in brain of senescence-accelerated-prone mouse SAMP8.
Fernández-Gómez FJ; Muñoz-Delgado E; Montenegro MF; Campoy FJ; Vidal CJ; Jordán J
J Neurosci Res; 2010 Jan; 88(1):155-66. PubMed ID: 19610099
[TBL] [Abstract][Full Text] [Related]
16. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
[TBL] [Abstract][Full Text] [Related]
17. Novel frame-shift mutation in Slc5a2 encoding SGLT2 in a strain of senescence-accelerated mouse SAMP10.
Unno K; Yamamoto H; Toda M; Hagiwara S; Iguchi K; Hoshino M; Takabayashi F; Hasegawa-Ishii S; Shimada A; Hosokawa M; Higuchi K; Mori M
Biochem Biophys Res Commun; 2014 Nov; 454(1):89-94. PubMed ID: 25450362
[TBL] [Abstract][Full Text] [Related]
18. Limited impairments of associative learning in a mouse model of accelerated senescence.
Yang Y; Wu GY; Li X; Huang H; Hu B; Yao J; Wu B; Sui JF
Behav Brain Res; 2013 Nov; 257():140-7. PubMed ID: 24076384
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of cathepsins E and D in reactive microglial cells associated with spongiform degeneration in the brain stem of senescence-accelerated mouse.
Amano T; Nakanishi H; Oka M; Yamamoto K
Exp Neurol; 1995 Dec; 136(2):171-82. PubMed ID: 7498407
[TBL] [Abstract][Full Text] [Related]
20. [The senescence-accelerated mouse as a model for geriatrics and aging biology].
Mori M; Higuchi K
Nihon Yakurigaku Zasshi; 2019; 153(4):179-185. PubMed ID: 30971658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
